Attovia Therapeutics, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Attovia Therapeutics, Inc.'s yearly results, compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
—Data incomplete
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-30.8×Operating cash was negative last year, while some debt falls due within a year.
Lower than 64% of Healthcare companies in United States.
Cash Cushion Ratio
+22%Cash, after subtracting all debt, equals 22% of its market value (net cash).
Higher than 64% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (9)
Attovia Therapeutics, Inc. made a loss over the last year. Attovia Therapeutics, Inc. owes $2.13 for every $1 it owns. Attovia Therapeutics, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossAttovia Therapeutics, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-4.55Attovia Therapeutics, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$662 MThe total market value of all of Attovia Therapeutics, Inc.'s shares at today's price (share price × number of shares), larger than 59% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
NegativeAttovia Therapeutics, Inc.'s net worth is negative ($145 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
2.13×Attovia Therapeutics, Inc. owes $2.13 for every $1 it owns, so it owes more than it owns, higher than 96% of Healthcare companies in United States.
Dividend yield
NoneAttovia Therapeutics, Inc. does not currently pay a dividend.
Profit growth
LossAttovia Therapeutics, Inc. made a loss in each of the last two years.
Profit margin
-4490.9%Attovia Therapeutics, Inc. lost $4491 for every $100 of revenue.
Cash vs debt
Net cashAttovia Therapeutics, Inc. held $147 M more cash than debt (net cash) at Dec 2025.
Questions
How much does Attovia Therapeutics, Inc. owe compared with what it owns?
Attovia Therapeutics, Inc. owes $2.13 for every $1 it owns, so it owes more than it owns, higher than 96% of Healthcare companies in United States.
Does Attovia Therapeutics, Inc. pay a dividend?
No. Attovia Therapeutics, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.